Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
PLX	PROTALIX BIOTHERAPEUTICS INC	$3.07	3.72%	3.72%	19.92%	28.99%	162.39%	169.30%	171.68%	-18.13%	-86.05%	$3.10	$0.82	0.97%	273.93%	0.65	913,963	35.48%
AUPH	AURINIA PHARMACEUTICALS INC	$8.24	1.48%	1.85%	2.49%	3.00%	11.96%	61.89%	-24.33%	-52.20%	115.71%	$10.67	$4.99	22.77%	65.13%	1.06	1,071,675	18.10%
CPRX	CATALYST PHARMACEUTICALS INC	$24.29	0.04%	5.06%	0.16%	4.74%	12.66%	61.40%	211.01%	412.45%	668.67%	$26.16	$14.47	7.14%	67.86%	1.07	941,751	31.23%
NAGE	NIAGEN BIOSCIENCE INC	$7.85	0.90%	9.18%	13.77%	33.50%	119.27%	121.75%	294.47%	57.00%	119.89%	$9.18	$2.31	14.49%	240.56%	1.23	411,930	11.05%
RIGL	RIGEL PHARMACEUTICALS INC	$19.56	-0.05%	7.71%	8.73%	-13.45%	37.07%	86.29%	-20.49%	9.27%	-54.08%	$29.82	$7.48	34.41%	161.36%	1.38	146,975	-24.48%
BMRN	BIOMARIN PHARMACEUTICAL INC	$63.69	0.65%	2.83%	-9.90%	-0.30%	-4.48%	-21.14%	-23.55%	-30.79%	-43.16%	$94.85	$52.93	32.85%	20.33%	0.74	1,296,496	5.74%
EXEL	EXELIXIS INC	$39.15	1.56%	6.44%	6.04%	18.89%	20.68%	66.88%	72.77%	58.53%	1,423.35%	$40.02	$20.14	2.17%	94.39%	0.62	2,150,698	20.40%
INCY	INCYTE CORP	$62.66	3.69%	8.03%	3.48%	-15.06%	-15.24%	20.38%	-17.61%	-35.84%	-35.51%	$83.95	$52.28	25.36%	19.85%	0.58	2,822,211	-3.74%
JAZZ	JAZZ PHARMACEUTICALS PLC	$116.96	0.47%	12.26%	-5.79%	-6.47%	3.34%	5.61%	-25.65%	6.09%	-34.55%	$148.06	$95.49	21.00%	22.48%	0.71	1,127,014	5.56%
TECH	BIO-TECHNE CORP	$50.35	-0.30%	0.38%	-14.12%	-30.80%	-33.77%	-20.34%	-47.36%	-10.49%	109.88%	$85.57	$46.01	41.16%	9.43%	1.13	1,529,977	14.57%
CSBR	CHAMPIONS ONCOLOGY INC	$7.15	-4.92%	-9.15%	-17.63%	-33.18%	88.65%	47.42%	-6.29%	-7.38%	-2.32%	$11.99	$3.60	40.37%	98.61%	0.51	26,771	2.34%
CRMD	CORMEDIX INC	$9.19	0.77%	8.76%	49.19%	-16.23%	-8.56%	74.88%	160.34%	121.45%	-75.49%	$13.85	$3.61	33.65%	154.57%	1.08	1,167,234	75.56%
XERS	XERIS BIOPHARMA HOLDINGS INC	$4.57	3.63%	10.65%	-16.76%	24.86%	41.49%	161.14%	85.77%	69.26%	N/A	$6.07	$1.72	24.71%	165.70%	1.23	2,089,633	22.67%
GMAB	GENMAB A	$21.15	1.73%	5.07%	8.02%	6.76%	-6.29%	-23.62%	-39.24%	-13.07%	174.11%	$30.41	$17.24	30.45%	22.72%	0.72	1,354,443	10.03%
HALO	HALOZYME THERAPEUTICS INC	$61.42	0.99%	5.15%	-3.75%	8.86%	21.41%	61.21%	50.35%	171.11%	313.05%	$66.00	$38.88	6.94%	57.97%	0.85	1,366,117	19.00%
FOLD	AMICUS THERAPEUTICS INC	$7.68	2.13%	8.17%	-5.88%	-20.33%	-33.68%	-23.12%	9.56%	-34.97%	-23.66%	$12.65	$6.20	39.29%	23.87%	1.02	4,493,423	20.17%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$14.91	1.08%	3.18%	-4.67%	9.07%	75.00%	79.21%	-30.13%	-49.83%	N/A	$17.75	$6.99	16.00%	113.30%	1.19	1,274,440	-12.10%
HRTX	HERON THERAPEUTICS INC	$2.42	3.42%	10.00%	10.00%	39.88%	34.44%	4.31%	-49.48%	-83.03%	-77.59%	$3.93	$1.04	38.42%	132.69%	1.48	1,107,234	-5.65%
UTHR	UNITED THERAPEUTICS CORP	$303.09	0.77%	3.28%	-1.68%	-13.97%	-16.13%	29.34%	68.55%	176.64%	89.80%	$417.82	$253.93	27.46%	19.36%	0.49	784,301	36.43%
NVO	NOVO NORDISK A S	$66.45	1.98%	8.40%	-4.31%	-22.13%	-41.32%	-48.21%	16.74%	109.85%	136.18%	$148.15	$57.00	55.15%	16.58%	0.57	9,214,791	-15.64%
THTX	THERATECHNOLOGIES INC	$2.84	-0.87%	5.19%	102.86%	97.22%	127.20%	118.46%	-70.90%	-71.60%	-24.47%	$3.13	$1.08	9.27%	162.96%	0.77	327,866	10.40%
PBYI	PUMA BIOTECHNOLOGY INC	$3.18	4.61%	4.95%	7.43%	4.61%	11.97%	-37.28%	37.66%	-68.36%	-98.24%	$5.26	$2.23	39.54%	42.92%	0.96	545,175	158.83%
VRTX	VERTEX PHARMACEUTICALS INC	$509.50	1.19%	3.47%	5.09%	16.22%	7.25%	29.71%	94.50%	102.83%	313.29%	$519.88	$377.85	2.00%	34.84%	0.57	1,422,831	13.38%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$26.97	4.21%	29.17%	21.43%	35.66%	17.21%	44.07%	186.61%	35.19%	N/A	$28.15	$17.38	4.19%	55.18%	0.95	1,483,410	-26.46%
ACAD	ACADIA PHARMACEUTICALS INC	$14.60	1.18%	-0.14%	-12.10%	-21.88%	-1.15%	-12.63%	-25.28%	-69.78%	-57.27%	$20.68	$13.40	29.40%	8.96%	0.88	1,863,243	17.40%
KURA	KURA ONCOLOGY INC	$6.56	0.61%	2.98%	-0.61%	-18.31%	-61.34%	-66.56%	-56.18%	-54.91%	N/A	$23.48	$5.41	72.06%	21.26%	1.04	967,136	11.78%
RPRX	ROYALTY PHARMA PLC	$32.82	0.34%	3.57%	5.43%	3.89%	20.71%	18.48%	-22.50%	N/A	N/A	$34.20	$24.05	4.04%	36.47%	0.53	4,545,721	73.97%
SRPT	SAREPTA THERAPEUTICS INC	$62.40	2.55%	4.89%	-2.23%	-45.48%	-51.17%	-50.73%	-15.42%	-47.06%	411.48%	$173.25	$48.01	63.98%	29.97%	0.91	1,576,612	-21.01%
TGTX	TG THERAPEUTICS INC	$45.51	3.76%	15.24%	15.42%	36.42%	81.10%	233.16%	502.78%	286.99%	226.00%	$45.83	$15.16	0.70%	200.20%	1.87	3,266,102	21.23%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$29.47	0.10%	1.97%	-11.21%	-25.47%	-12.81%	-4.66%	-34.66%	N/A	N/A	$41.61	$26.47	29.18%	11.33%	0.85	435,201	4.86%
MDXG	MIMEDX GROUP INC	$6.88	-0.58%	1.78%	-9.47%	-22.78%	20.91%	11.69%	74.18%	N/A	-26.81%	$10.14	$5.47	32.15%	25.78%	1.22	703,474	18.73%
MNKD	MANNKIND CORP	$5.04	2.65%	9.33%	0.20%	-15.58%	-28.21%	22.63%	53.66%	287.69%	-76.50%	$7.63	$4.17	33.94%	21.01%	1.10	2,007,597	6.22%
INVA	INNOVIVA INC	$18.69	0.92%	1.74%	3.09%	-1.11%	-5.18%	23.69%	14.59%	31.81%	15.02%	$21.28	$15.07	12.17%	24.02%	0.51	551,512	-3.79%
FENC	FENNEC PHARMACEUTICALS INC	$6.04	-2.42%	6.90%	-0.82%	-7.79%	35.12%	-34.20%	-1.79%	-3.36%	152.72%	$10.07	$3.96	40.00%	52.53%	0.67	66,367	59.14%
BCRX	BIOCRYST PHARMACEUTICALS INC	$8.85	4.86%	11.18%	18.00%	12.45%	5.73%	114.29%	-7.81%	126.34%	-4.74%	$9.50	$4.41	6.84%	100.68%	1.18	4,793,418	-3.51%
ARGX	ARGENX SE	$645.14	2.48%	8.49%	9.00%	-3.09%	16.93%	71.81%	119.92%	340.40%	N/A	$678.21	$352.77	4.88%	82.88%	0.70	319,772	38.37%
LGND	LIGAND PHARMACEUTICALS INC	$109.86	-1.36%	3.88%	4.49%	-7.40%	0.05%	57.19%	14.35%	11.45%	41.50%	$129.90	$70.86	15.43%	55.05%	1.10	105,655	25.94%
TARS	TARSUS PHARMACEUTICALS INC	$51.91	1.98%	3.82%	1.05%	0.33%	16.05%	65.16%	270.79%	N/A	N/A	$57.28	$20.08	9.38%	158.49%	0.92	598,226	-55.33%
GLUE	MONTE ROSA THERAPEUTICS INC	$4.91	2.51%	-7.88%	5.82%	-23.88%	-46.75%	-7.71%	-58.91%	N/A	N/A	$12.40	$3.21	60.40%	52.96%	1.69	340,790	5.00%
ABUS	ARBUTUS BIOPHARMA CORP	$3.55	4.11%	9.57%	1.72%	7.58%	-9.90%	30.04%	45.49%	206.03%	-77.05%	$4.73	$2.63	24.87%	34.98%	0.84	1,143,983	20.41%
ARDX	ARDELYX INC	$5.51	1.01%	13.51%	12.12%	2.71%	-6.54%	-13.98%	556.92%	-16.34%	-47.57%	$9.33	$4.02	41.00%	36.94%	1.21	3,925,086	-21.50%
ALNY	ALNYLAM PHARMACEUTICALS INC	$263.24	2.35%	8.79%	-2.51%	-5.02%	-6.48%	82.87%	89.31%	99.88%	158.41%	$304.39	$144.73	13.52%	81.88%	0.89	949,165	0.81%
VCEL	VERICEL CORP	$38.02	-3.40%	-5.07%	-14.79%	-35.83%	-16.51%	-17.11%	26.90%	162.21%	1,048.64%	$63.00	$37.76	39.65%	0.69%	1.43	384,627	-2.00%
IVVD	INVIVYD INC	$0.63	-0.79%	-2.17%	4.13%	61.54%	-30.77%	-71.62%	-79.28%	N/A	N/A	$2.74	$0.36	77.01%	77.46%	1.14	1,103,171	34.38%
STOK	STOKE THERAPEUTICS INC	$9.76	2.63%	2.52%	46.77%	-11.19%	-21.92%	-11.51%	-34.89%	-53.59%	N/A	$17.58	$5.35	44.48%	82.43%	1.39	571,585	-23.86%
CTMX	CYTOMX THERAPEUTICS INC	$0.74	14.11%	1.92%	16.98%	-14.97%	-25.00%	-54.36%	-59.12%	-92.79%	N/A	$5.06	$0.40	85.30%	86.00%	1.03	1,651,000	-17.13%
ASND	ASCENDIS PHARMA A	$170.44	2.32%	7.78%	9.35%	33.89%	38.79%	23.11%	87.19%	25.57%	900.82%	$171.34	$111.09	0.52%	53.43%	0.68	377,765	36.42%
VRNA	VERONA PHARMA PLC	$72.07	-1.56%	13.84%	13.51%	25.91%	110.79%	366.47%	1,747.95%	1,599.76%	N/A	$74.18	$11.39	2.84%	532.75%	0.79	1,469,937	-73.96%
KRYS	KRYSTAL BIOTECH INC	$169.88	-0.40%	2.46%	-5.78%	8.85%	-3.22%	10.95%	166.90%	259.99%	N/A	$219.34	$141.72	22.55%	19.87%	1.34	210,944	-18.09%
CORT	CORCEPT THERAPEUTICS INC	$71.88	-1.84%	3.77%	-37.07%	2.83%	53.29%	208.23%	225.99%	467.77%	1,145.75%	$117.33	$23.02	38.74%	212.25%	0.92	809,594	-0.91%
LEGN	LEGEND BIOTECH CORP	$34.95	1.51%	1.90%	3.01%	-6.10%	-21.05%	-20.10%	-16.65%	N/A	N/A	$60.87	$29.27	42.58%	19.43%	0.76	1,088,100	54.79%
TLX	TELIX PHARMACEUTICALS LTD	$17.40	0.23%	-4.92%	3.82%	-4.40%	N/A	N/A	N/A	N/A	N/A	$30.36	$13.61	42.69%	27.85%	0.97	10,071	-41.38%
ABEO	ABEONA THERAPEUTICS INC	$6.56	23.77%	25.67%	37.82%	19.93%	3.14%	58.45%	21.71%	-88.97%	-90.66%	$7.32	$3.84	10.43%	70.83%	0.77	18,475,711	23.94%
ADMA	ADMA BIOLOGICS INC	$23.80	-1.29%	9.53%	19.96%	47.83%	40.33%	265.03%	1,159.26%	706.78%	183.00%	$25.67	$6.60	7.28%	260.61%	1.06	2,807,404	-45.03%
IMAB	I-MAB	$0.94	15.76%	10.72%	14.08%	-11.32%	-15.32%	-46.89%	-93.16%	-94.78%	N/A	$2.00	$0.60	53.00%	57.98%	1.11	190,008	1,328.42%
XOMA	XOMA ROYALTY CORP	$24.04	-1.39%	3.00%	20.62%	-8.45%	-19.49%	-5.13%	23.98%	-1.80%	-59.93%	$35.00	$18.35	31.31%	30.99%	0.86	34,112	121.15%
VCYT	VERACYTE INC	$30.50	-2.80%	-3.07%	2.87%	-33.90%	-12.86%	55.85%	41.27%	13.09%	233.33%	$47.32	$19.71	35.54%	54.74%	1.92	1,071,053	28.38%
MGTX	MEIRAGTX HOLDINGS PLC	$7.09	2.75%	9.24%	4.57%	10.26%	20.58%	45.29%	-31.43%	-48.51%	N/A	$8.75	$3.85	18.97%	84.16%	1.21	306,190	17.29%
ONC	BEIGENE LTD	$259.81	4.02%	4.29%	-4.54%	14.51%	26.13%	68.77%	56.01%	70.00%	N/A	$287.88	$141.31	9.75%	83.86%	0.94	353,049	9.92%
GYRE	GYRE THERAPEUTICS INC	$9.76	1.99%	6.20%	26.42%	-15.13%	-33.65%	-37.44%	37.81%	-89.26%	-99.73%	$19.00	$6.11	48.63%	59.74%	1.13	84,234	49.06%
ENTA	ENANTA PHARMACEUTICALS INC	$6.09	5.18%	8.75%	10.33%	18.48%	-47.00%	-55.68%	-90.51%	-86.87%	-82.21%	$17.24	$4.09	64.66%	48.90%	0.90	122,474	33.92%
VNDA	VANDA PHARMACEUTICALS INC	$4.51	1.81%	4.16%	-1.74%	-1.53%	-1.10%	-5.25%	-55.87%	-60.78%	-50.71%	$6.75	$3.85	33.19%	17.14%	0.73	321,363	-29.84%
DOMH	DOMINARI HOLDINGS INC	$4.59	-1.71%	1.32%	14.75%	28.21%	168.42%	93.67%	-23.45%	-62.45%	-99.54%	$13.58	$0.83	66.20%	455.69%	1.04	104,051	-32.00%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$24.43	0.95%	2.22%	11.30%	38.81%	N/A	N/A	N/A	N/A	N/A	$26.50	$17.00	7.81%	43.71%	0.62	20,917	176.68%
GOSS	GOSSAMER BIO INC	$1.02	15.65%	13.97%	-7.27%	5.81%	13.84%	43.66%	-85.71%	-92.17%	N/A	$1.55	$0.50	34.19%	104.41%	1.37	3,272,781	456.21%
PTCT	PTC THERAPEUTICS INC	$49.84	0.65%	-0.22%	-2.20%	8.00%	22.58%	55.02%	37.76%	-2.12%	-15.17%	$58.38	$28.72	14.63%	73.54%	0.96	1,041,539	58.77%
WVE	WAVE LIFE SCIENCES LTD	$7.72	5.18%	13.70%	-4.46%	-35.99%	-46.09%	56.59%	315.05%	-11.06%	N/A	$16.74	$4.25	53.87%	81.65%	1.39	2,100,039	21.48%
IBRX	IMMUNITYBIO INC	$2.51	0.80%	-6.69%	-16.61%	-27.67%	-55.50%	-68.59%	-36.93%	-35.64%	N/A	$10.01	$2.28	74.93%	10.09%	1.97	3,442,329	-22.35%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$7.36	-3.29%	-0.27%	-0.94%	-6.36%	45.45%	180.92%	-15.01%	-77.01%	N/A	$9.01	$2.74	18.31%	168.61%	1.87	1,990,964	18.41%
NVAX	NOVAVAX INC	$6.67	3.89%	-10.71%	4.06%	-25.97%	-32.22%	54.04%	-87.59%	-63.21%	-95.69%	$23.86	$4.43	72.05%	50.56%	1.52	5,219,775	2.76%
TBPH	THERAVANCE BIOPHARMA INC	$9.77	2.84%	3.39%	9.41%	1.03%	15.35%	15.76%	-4.12%	-66.50%	-38.94%	$10.90	$7.44	10.37%	31.32%	0.60	239,687	7.02%
CVAC	CUREVAC NV	$3.55	0.57%	11.99%	28.16%	-7.07%	26.79%	40.87%	-79.34%	N/A	N/A	$5.28	$2.37	32.77%	49.79%	1.19	603,544	-35.00%
NTRB	NUTRIBAND INC	$6.88	21.13%	31.55%	12.23%	-12.91%	11.51%	98.84%	94.35%	-33.11%	N/A	$11.78	$3.30	41.60%	108.48%	0.51	614,237	2,757.31%
MIRM	MIRUM PHARMACEUTICALS INC	$43.45	2.14%	9.67%	-3.55%	-10.30%	10.90%	73.04%	78.37%	157.10%	N/A	$54.23	$23.83	19.88%	82.33%	0.76	351,176	-20.93%
FHTX	FOGHORN THERAPEUTICS INC	$4.20	-1.18%	-10.26%	15.07%	-3.23%	-47.76%	-23.08%	-65.40%	N/A	N/A	$10.25	$2.95	59.02%	42.61%	1.47	115,356	39.71%
MESO	MESOBLAST LTD	$11.40	-4.28%	2.70%	-8.65%	-41.60%	29.40%	72.73%	54.05%	-48.83%	N/A	$22.00	$5.78	48.18%	97.23%	1.27	92,794	-32.20%
KLRS	KALARIS THERAPEUTICS INC	$6.27	-9.13%	-10.56%	-21.92%	-33.37%	-69.23%	-65.68%	-94.01%	N/A	N/A	$24.15	$5.87	74.04%	6.91%	1.47	24,807	-81.17%
SPRY	ARS PHARMACEUTICALS INC	$13.97	0.36%	-2.85%	11.05%	-2.24%	-2.10%	60.57%	343.49%	N/A	N/A	$18.51	$7.55	24.53%	85.03%	1.02	1,025,554	54.15%
AKBA	AKEBIA THERAPEUTICS INC	$2.41	-0.82%	11.57%	25.52%	4.78%	41.76%	91.27%	460.47%	-70.25%	-68.58%	$2.89	$0.80	16.61%	201.25%	1.67	3,573,486	26.65%
APLS	APELLIS PHARMACEUTICALS INC	$19.21	5.49%	9.83%	-12.16%	-36.79%	-30.67%	-56.53%	-57.27%	-43.95%	N/A	$49.06	$16.98	60.84%	13.17%	1.01	2,626,605	-17.39%
ANAB	ANAPTYSBIO INC	$22.22	4.91%	8.81%	19.53%	27.55%	0.18%	-8.71%	-7.61%	42.25%	N/A	$41.31	$12.21	46.21%	81.98%	0.83	581,339	68.00%
CLLS	CELLECTIS SA	$1.65	3.46%	12.67%	32.66%	4.11%	-9.62%	-35.74%	-54.05%	-87.39%	-95.00%	$3.38	$1.10	51.33%	49.55%	1.45	44,679	4.73%
ZVRA	ZEVRA THERAPEUTICS INC	$7.33	1.38%	1.10%	-2.14%	-8.60%	-13.05%	60.04%	59.69%	52.71%	-95.85%	$9.76	$4.20	24.90%	74.52%	0.79	275,336	-17.61%
TVTX	TRAVERE THERAPEUTICS INC	$20.81	3.64%	24.61%	16.13%	-1.14%	17.21%	276.31%	-19.12%	36.73%	-3.39%	$25.29	$5.79	17.71%	259.41%	1.06	1,514,352	28.79%
TLSA	TIZIANA LIFE SCIENCES LTD	$1.36	9.68%	3.82%	25.93%	97.67%	15.25%	107.00%	33.33%	22.74%	N/A	$1.91	$0.54	28.80%	150.00%	0.76	297,306	120.65%
NKTR	NEKTAR THERAPEUTICS	$0.80	7.29%	15.89%	16.91%	-6.58%	-36.40%	-45.55%	-82.33%	-95.86%	-91.65%	$1.93	$0.43	58.77%	84.03%	1.44	2,407,863	153.13%
BNTX	BIONTECH SE	$104.15	0.14%	-9.30%	14.38%	-13.84%	-8.59%	17.26%	-28.68%	119.36%	N/A	$131.49	$76.53	20.79%	36.09%	0.95	872,384	-31.42%
CANF	CAN-FITE BIOPHARMA LTD	$1.09	0.00%	-7.63%	-26.35%	-29.68%	-51.98%	-47.34%	-88.80%	-94.01%	-99.73%	$4.69	$1.03	76.76%	6.34%	0.53	219,987	59.47%
BNTC	BENITEC BIOPHARMA INC	$13.59	-0.66%	-0.51%	4.46%	24.56%	28.69%	60.83%	-46.35%	-91.22%	N/A	$16.90	$5.74	19.59%	136.68%	0.68	87,068	665.50%
UPB	UPSTREAM BIO INC	$9.26	3.12%	5.11%	51.31%	-15.82%	-62.81%	N/A	N/A	N/A	N/A	$29.46	$5.14	68.57%	80.16%	1.09	189,688	-12.56%
PULM	PULMATRIX INC	$6.61	4.92%	2.16%	-0.75%	-13.82%	203.21%	247.89%	24.72%	-76.05%	-99.61%	$10.40	$1.72	36.44%	284.30%	0.53	5,655	84.02%
CAPR	CAPRICOR THERAPEUTICS INC	$12.70	1.11%	-3.42%	33.83%	-16.45%	-40.54%	140.99%	264.94%	81.43%	-78.74%	$23.40	$3.52	45.73%	260.80%	0.92	562,527	-28.74%
INO	INOVIO PHARMACEUTICALS INC	$1.94	1.57%	3.74%	19.02%	-7.18%	-65.11%	-83.06%	-94.57%	-98.66%	-98.02%	$13.44	$1.42	85.57%	36.62%	1.37	512,462	133.18%
RGNX	REGENXBIO INC	$9.61	2.13%	8.34%	34.41%	21.65%	8.71%	-37.39%	-66.21%	-75.87%	N/A	$17.52	$5.04	45.15%	90.86%	1.33	575,371	-18.93%
PTGX	PROTAGONIST THERAPEUTICS INC	$45.82	0.44%	-0.74%	-5.25%	17.13%	-3.78%	82.48%	373.35%	578.81%	N/A	$60.60	$25.23	24.39%	81.61%	1.17	860,805	-31.40%
MRUS	MERUS NV	$45.51	1.02%	8.80%	8.13%	9.48%	-11.25%	1.34%	113.96%	206.67%	N/A	$61.61	$33.19	26.13%	37.12%	0.91	308,666	-10.59%
MDGL	MADRIGAL PHARMACEUTICALS INC	$333.91	-2.02%	8.13%	0.81%	-1.29%	54.64%	63.67%	367.27%	299.03%	324.01%	$377.46	$200.08	11.54%	66.89%	0.78	412,942	30.47%
LXRX	LEXICON PHARMACEUTICALS INC	$0.73	9.27%	8.78%	58.57%	-10.74%	-62.51%	-52.53%	-62.12%	-61.32%	-89.56%	$2.45	$0.28	70.16%	157.39%	1.37	5,578,978	61.82%
HURA	TUHURA BIOSCIENCES INC	$3.78	-3.57%	-10.00%	17.03%	-23.17%	-37.93%	-30.45%	-99.20%	-99.59%	-99.99%	$14.60	$1.80	74.10%	110.00%	0.85	136,014	-26.69%
IKT	INHIBIKASE THERAPEUTICS INC	$2.26	0.44%	4.63%	3.20%	17.71%	-18.41%	53.74%	-65.44%	N/A	N/A	$4.20	$1.12	46.19%	101.79%	0.87	131,592	0.10%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: A.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 169.3% over the past year, overperforming other biotech stocks by 246 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 388.6% from Protalix Biotherapeutics's current stock price of $3.07.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 61.89% over the past year, overperforming other biotech stocks by 139 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 61.4% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.68% from Catalyst Pharmaceuticals's current stock price of $24.29.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.97%, which is 5 percentage points higher than the biotech industry average of 1.92%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.43%, which is 1 percentage points higher than the biotech industry average of 1.92%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.31%, which is -1 percentage points lower than the biotech industry average of 1.92%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.74% in the last day, and up 4.52% over the last week. Regulus Therapeutics was the among the top gainers in the biotechnology industry, gaining 136.8% yesterday.

Regulus Therapeutics shares are trading higher after the company announced it entered into an agreement to be acquired by Novartis AG for $7 in cash per share.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -4.66% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.28% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 5.61% in the past year. It has overperformed other stocks in the biotech industry by 82 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 100.94% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.14% of biotech stocks are rated B (Buy), 42.05% are rated C (Hold), 36.38% are rated D (Sell), and 15.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -162.28x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.